Back to Search
PRIYA RAJAGOPALAN, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1598173528IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
MD462252(PA)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
OTHER
Class of 2000
Research & Publications (20)
Direct comparison of the spread area, contractility, and migration of balb/c 3T3 fibroblasts adhered to fibronectin- and RGD-modified substrata.
PMID 15454473·Biophys J·2004
4-observational
Population pharmacokinetics of ciprofloxacin in pediatric patients.
PMID 12856383·J Clin Pharmacol·2003
8-other
Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction.
PMID 12638394·J Clin Pharmacol·2003
3-trial
Enteral fluconazole population pharmacokinetics in patients in the surgical intensive care unit.
PMID 12741433·Pharmacotherapy·2003
3-trial
Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics.
PMID 12359872·Proc Natl Acad Sci U S A·2002
8-other
Coupling interactions of distal residues enhance dihydrofolate reductase catalysis: mutational effects on hydride transfer rates.
PMID 12379104·Biochemistry·2002
8-other
Characterization of cobalt(II)-substituted peptide deformylase: function of the metal ion and the catalytic residue Glu-133.
PMID 10651644·Biochemistry·2000
4-observational
UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib.
PMID 19672597·Cancer Chemother Pharmacol·2009
5-case
Nano- and sub-micron porous polyelectrolyte multilayer assemblies: biomimetic surfaces for human corneal epithelial cells.
PMID 19446874·Biomaterials·2009
8-other
HCV NS5B polymerase inhibitors 2: Synthesis and in vitro activity of (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivatives.
PMID 19500983·Bioorg Med Chem Lett·2009
7-preclinical
Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors.
PMID 19636022·J Clin Oncol·2009
3-trial
Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor.
PMID 18519779·Clin Cancer Res·2008
3-trial
Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227).
PMID 18824605·Antimicrob Agents Chemother·2008
7-preclinical
Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours.
PMID 19002179·Br J Cancer·2008
3-trial
The use of elastin-like polypeptide-polyelectrolyte complexes to control hepatocyte morphology and function in vitro.
PMID 18006054·Biomaterials·2008
7-preclinical
Cellular response to nanoscale elastin-like polypeptide polyelectrolyte multilayers.
PMID 18178532·Acta Biomater·2008
7-preclinical
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy.
PMID 18279104·J Interferon Cytokine Res·2008
3-trial
A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation.
PMID 17564637·Am J Transplant·2007
3-trial
Hallmarks of mycolic acid biosynthesis: a comparative genomics study.
PMID 17600834·Proteins·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 875 POPLAR CHURCH RD STE 400
CAMP HILL, PA 17011 - Phone
- (717) 724-6450
Quick Facts
- NPI
- 1598173528
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 3
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile